Objective: To investigate whether intravenous immunoglobulin (IVIG) can improve the chance of livebirth in women with a history of recurrent spontaneous miscarriage (RM). Study design: Randomized, double-blind, placebo- controlled trial. Patients and interventions: Fifty four women with a history of secondary (RM) were randomly assigned to receive doses of (IVIG) or placebo (Saline) starting as soon as pregnancy test was positive. Results: The live birth rate (LBR) was significantly higher in the IVIG group when compared with placebo-infused group even after exclusion of cases of ectopic pregnancy and cases with low serum ~hCG and progesterone levels,
Ghali, H., & Mansour, H. (2006). PASSIVE IMMUNIZATION IN THE CLINICAL MANAGEMENT OF SECONDARY SPONTANEOUS RECURRENT MISCARRIAGE. The Egyptian Journal of Fertility and Sterility, 10(1), 9-16. doi: 10.21608/egyfs.2006.4992
MLA
Hanan Ghali; HodaA. Mansour. "PASSIVE IMMUNIZATION IN THE CLINICAL MANAGEMENT OF SECONDARY SPONTANEOUS RECURRENT MISCARRIAGE", The Egyptian Journal of Fertility and Sterility, 10, 1, 2006, 9-16. doi: 10.21608/egyfs.2006.4992
HARVARD
Ghali, H., Mansour, H. (2006). 'PASSIVE IMMUNIZATION IN THE CLINICAL MANAGEMENT OF SECONDARY SPONTANEOUS RECURRENT MISCARRIAGE', The Egyptian Journal of Fertility and Sterility, 10(1), pp. 9-16. doi: 10.21608/egyfs.2006.4992
VANCOUVER
Ghali, H., Mansour, H. PASSIVE IMMUNIZATION IN THE CLINICAL MANAGEMENT OF SECONDARY SPONTANEOUS RECURRENT MISCARRIAGE. The Egyptian Journal of Fertility and Sterility, 2006; 10(1): 9-16. doi: 10.21608/egyfs.2006.4992
)
View on SCiNiTO